• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by Guardian Pharmacy Services Inc.

    11/12/25 9:33:33 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $GRDN alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    Guardian Pharmacy Services, Inc.

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)


    40145W101

    (CUSIP Number)


    09/30/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    40145W101


    1Names of Reporting Persons

    Wellington Management Group LLP
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    MASSACHUSETTS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    803,853.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,143,729.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,143,729.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.0 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    CUSIP No.
    40145W101


    1Names of Reporting Persons

    Wellington Group Holdings LLP
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    803,853.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,143,729.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,143,729.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.0 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    CUSIP No.
    40145W101


    1Names of Reporting Persons

    Wellington Investment Advisors Holdings LLP
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    803,853.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,143,729.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,143,729.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.0 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Guardian Pharmacy Services, Inc.
    (b)Address of issuer's principal executive offices:

    300 Galleria Parkway Southeast, Suite 800, Atlanta GA 30339
    Item 2. 
    (a)Name of person filing:

    Wellington Management Group LLP Wellington Group Holdings LLP Wellington Investment Advisors Holdings LLP
    (b)Address or principal business office or, if none, residence:

    c/o Wellington Management Company LLP, 280 Congress Street, Boston MA 02210
    (c)Citizenship:

    Wellington Management Group LLP - Massachusetts Wellington Group Holdings LLP - Delaware Wellington Investment Advisors Holdings LLP - Delaware
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    40145W101
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    See the responses to Item 9 on the attached cover pages.
    (b)Percent of class:

    5.03  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    0

     (ii) Shared power to vote or to direct the vote:

    See the responses to Item 6 on the attached cover pages.

     (iii) Sole power to dispose or to direct the disposition of:

    0

     (iv) Shared power to dispose or to direct the disposition of:

    See the responses to Item 8 on the attached cover pages.

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    The securities as to which this Schedule is filed are owned of record by clients of one or more investment advisers identified in Item 7 directly or indirectly owned by Wellington Management Group LLP. Those clients have the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from the sale of, such securities. No such client is known to have such right or power with respect to more than five percent of this class of securities, except as follows: Not Applicable.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    Pursuant to the instructions in Item 7 of Schedule 13G, the following lists the identity and Item 3 classification of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Wellington Group Holdings LLP - HC Wellington Investment Advisors LLP - HC Wellington Management Global Holdings, Ltd. - HC One or more of the following investment advisers (the "Wellington Investment Advisers"): Wellington Management Company LLP - IA Wellington Management Canada LLC - IA Wellington Management Singapore Pte Ltd - IA Wellington Management Hong Kong Ltd - IA Wellington Management International Ltd - IA Wellington Management Japan Pte Ltd - IA Wellington Management Australia Pty Ltd - IA The securities as to which this Schedule is filed by Wellington Management Group LLP, as parent holding company of certain holding companies and the Wellington Investment Advisers, are owned of record by clients of the Wellington Investment Advisers. Wellington Investment Advisors Holdings LLP controls directly, or indirectly through Wellington Management Global Holdings, Ltd., the Wellington Investment Advisers. Wellington Investment Advisors Holdings LLP is owned by Wellington Group Holdings LLP. Wellington Group Holdings LLP is owned by Wellington Management Group LLP.
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Wellington Management Group LLP
     
    Signature:Taisia Lowe
    Name/Title:Regulatory Analyst
    Date:11/12/2025
     
    Wellington Group Holdings LLP
     
    Signature:Taisia Lowe
    Name/Title:Regulatory Analyst
    Date:11/12/2025
     
    Wellington Investment Advisors Holdings LLP
     
    Signature:Taisia Lowe
    Name/Title:Regulatory Analyst
    Date:11/12/2025
    Get the next $GRDN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GRDN

    DatePrice TargetRatingAnalyst
    10/10/2025$30.00Outperform
    Oppenheimer
    10/21/2024$21.00Outperform
    Raymond James
    10/21/2024$22.00Buy
    Truist
    More analyst ratings

    $GRDN
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Guardian Pharmacy Services Inc.

    SCHEDULE 13G/A - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

    11/14/25 2:52:55 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SCHEDULE 13G filed by Guardian Pharmacy Services Inc.

    SCHEDULE 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

    11/12/25 9:33:33 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 10-Q filed by Guardian Pharmacy Services Inc.

    10-Q - Guardian Pharmacy Services, Inc. (0001802255) (Filer)

    11/10/25 4:17:07 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Oppenheimer initiated coverage on Guardian Pharmacy Services with a new price target

    Oppenheimer initiated coverage of Guardian Pharmacy Services with a rating of Outperform and set a new price target of $30.00

    10/10/25 8:37:40 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Raymond James initiated coverage on Guardian Pharmacy Services with a new price target

    Raymond James initiated coverage of Guardian Pharmacy Services with a rating of Outperform and set a new price target of $21.00

    10/21/24 8:25:47 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Truist initiated coverage on Guardian Pharmacy Services with a new price target

    Truist initiated coverage of Guardian Pharmacy Services with a rating of Buy and set a new price target of $22.00

    10/21/24 7:42:42 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cosler Steven D bought $99,786 worth of shares (3,370 units at $29.61), increasing direct ownership by 16% to 24,984 units (SEC Form 4)

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    12/5/25 4:10:03 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Cosler Steven D bought $148,540 worth of shares (7,000 units at $21.22), increasing direct ownership by 65% to 17,713 units (SEC Form 4)

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    11/20/24 4:05:12 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Salentine Thomas J Jr bought $499,996 worth of shares (35,714 units at $14.00) (SEC Form 4)

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    10/1/24 5:48:50 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Forbes Kendall gifted 21,500 shares, decreasing direct ownership by 3% to 790,976 units (SEC Form 4)

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    12/8/25 4:10:02 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Officer Burke Fred gifted 200,000 shares, decreasing direct ownership by 12% to 1,511,845 units (SEC Form 4)

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    12/8/25 4:10:04 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Cosler Steven D bought $99,786 worth of shares (3,370 units at $29.61), increasing direct ownership by 16% to 24,984 units (SEC Form 4)

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    12/5/25 4:10:03 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Guardian Pharmacy Services Reports Third Quarter 2025 Financial Results; Raises Full-Year Guidance

    Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the third quarter ended September 30, 2025. The Company also raised its full-year revenue and Adjusted EBITDA guidance. Third Quarter Financial Results Revenue of $377.4 million, up 20% year-over-year. Residents served ended the quarter at approximately 204,000, up 13% year-over-year. Net Income (loss) of $9.6 million, compared to ($105.8) million in the prior-year period. Such year-over-year comparison is not meaningful due to income tax expense1 in the recently completed quarter, and certain one-time share-based

    11/10/25 4:05:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Guardian Pharmacy Services, Inc. to Participate in Upcoming Stephens Investment Conference

    Guardian Pharmacy Services, Inc. (NYSE:GRDN) today announced that it will participate in the Stephens Investment Conference in Nashville, TN, on Wednesday, November 19, 2025. The company will host investor meetings, and Fred Burke, Co-founder and Chief Executive Officer, will take part in a fireside chat at 11:00 a.m. CT (12:00 p.m. ET) the same day. A live audio webcast of the session will be available at https://investors.guardianpharmacy.com. A replay will be accessible shortly after the event and will remain available for 90 days. About Guardian Pharmacy Services Guardian Pharmacy Services is one of the nation's leading long-term care pharmacy services companies. Through its local

    10/28/25 4:30:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Guardian Pharmacy Services Announces Filing of S-3 Shelf Registration Statement and Lock-up Agreements with Pre-IPO Holders of Class A Common Stock

    Guardian Pharmacy Services, Inc. (NYSE:GRDN) ("Guardian"), one of the nation's leading long-term care (LTC) pharmacy services companies, today announced that it has filed a shelf registration statement on Form S-3 with the U.S. Securities and Exchange Commission (SEC). The registration statement relates to (i) the possible issuance and sale of up to 1,020,000 shares of Class A common stock by Guardian and (ii) the potential resale of up to 4,980,000 outstanding shares of Class A common stock by selling stockholders, in each case from time to time and on a continuous or delayed basis. Guardian recently became eligible to file a Form S-3 registration statement and determined that such filin

    10/14/25 4:47:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Leadership Updates

    Live Leadership Updates

    View All

    Guardian Pharmacy Services, Inc. Names Ashley Ragsdale Stockton as Head of Investor Relations

    Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies is pleased to announce the appointment of Ashley Stockton as Senior Director, Head of Investor Relations. She will be responsible for leading the investor relations strategy and serving as the primary liaison with shareholders, analysts, and the broader investment community. Ashley joins Guardian with nearly thirty years of experience in equity markets. Most recently, she served as Head of Southeast Institutional Equity Sales for J.P. Morgan, where she built and managed strategic partnerships with institutional investors, delivering dif

    5/8/25 4:05:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Guardian Pharmacy Services Expands to New Jersey Through Partnership with Freedom Pharmacy

    Guardian Pharmacy Services, (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies, today announced that Freedom Pharmacy, an independent LTC pharmacy based in Randolph, New Jersey, is joining the Guardian family. The pharmacy will continue to operate under the name Freedom Pharmacy and serve residents in assisted living and skilled nursing, as well as individuals with intellectual and developmental disabilities throughout North, Northwest and Central New Jersey, with plans to further increase its presence across the Garden State in the future. This strategic partnership expands Guardian's Mid-Atlantic footprint and marks its first vent

    12/17/24 9:00:00 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Financials

    Live finance-specific insights

    View All

    Guardian Pharmacy Services Reports Third Quarter 2025 Financial Results; Raises Full-Year Guidance

    Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the third quarter ended September 30, 2025. The Company also raised its full-year revenue and Adjusted EBITDA guidance. Third Quarter Financial Results Revenue of $377.4 million, up 20% year-over-year. Residents served ended the quarter at approximately 204,000, up 13% year-over-year. Net Income (loss) of $9.6 million, compared to ($105.8) million in the prior-year period. Such year-over-year comparison is not meaningful due to income tax expense1 in the recently completed quarter, and certain one-time share-based

    11/10/25 4:05:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Guardian Pharmacy Services, Inc. to Report Third Quarter 2025 Financial Results and Host Conference Call

    Guardian Pharmacy Services, Inc. (NYSE:GRDN) announced today that it will release its third quarter 2025 results on Monday, November 10th, 2025, after market close and host a conference call to review the results at 4:30 pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (646) 564-2877 for U.S. participants, or +1 (800) 549-8228 for international participants, and referencing conference ID "11965." A replay will be available shortly after the call's completion and will remain available for approximately 60 days. About Guardian Pharmacy Services Guardian Pharmacy Services

    10/6/25 8:30:00 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Guardian Pharmacy Services Reports Second Quarter 2025 Financial Results; Raises Full-Year Guidance

    Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the second quarter ended June 30, 2025. Second Quarter Financial Results Revenue of $344.3 million, up 15% year-over-year, driven by low double-digit organic growth and acquisitions completed over the past 12 months. Resident count ended the quarter over 195,000, up 12% year-over-year. Net Income of $8.8 million, compared to $15.8 million in the prior-year period. This is not a meaningful comparison primarily due to income tax1 and share-based compensation expenses2 in the recently completed quarter. Adjusted EB

    8/11/25 4:05:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

    SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

    12/6/24 12:05:09 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

    SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

    11/14/24 4:30:13 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

    SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

    11/14/24 1:01:24 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples